Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px
Collaboration › Details

Akoya Biosciences–JPMorgan Chase: investor conference, 202301 supply service Akoya presents at JP Morgan Healthcare Conference 2023

 

Period Period 2023-01-11
Region Region San Francisco, CA
  Country United States (USA)
Organisations Partner, 1st Akoya Biosciences Inc., Menlo Park
  Group Akoya Biosciences (Group)
  Partner, 2nd J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 41st Annual Healthcare Conference 2023 San Francisco
  Product 2 spatial omics
Persons Person McKelligon, Brian (Akoya Biosciences 201810 CEO)
  Person 2 Shah, Priyam (Akoya BIosciences 202212 Senior Director Investor Relations)
     

Akoya Biosciences, Inc.. (12/28/22). "Press Release: Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference". Marlborough, MA.

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference.

Brian McKelligon, CEO, is scheduled to present on Wednesday, January 11th, 2023 at 9:45 a.m. PT.

A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.


About Akoya Biosciences

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.


Investor Contact:

Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com


Media Contact:

Christine Quern
(617) 650-8497
media@akoyabio.com

   
Record changed: 2023-01-08

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Akoya Biosciences (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px




» top